4//SEC Filing
Spoor Johan M. 4
Accession 0000950170-25-033662
CIK 0000728387other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:27 PM ET
Size
6.0 KB
Accession
0000950170-25-033662
Insider Transaction Report
Form 4
Spoor Johan M.
DirectorChief Executive Officer
Transactions
- Award
Stock option (right to buy)
2025-03-03+650,000→ 650,000 totalExercise: $2.46Exp: 2035-03-03→ Common Stock (650,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025 (the "Grant Date"), and represents the Reporting Person's annual equity award for 2025.
- [F2]Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.
Documents
Issuer
Perspective Therapeutics, Inc.
CIK 0000728387
Entity typeother
Related Parties
1- filerCIK 0001535289
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:27 PM ET
- Size
- 6.0 KB